INS and metabolic dysfunction-associated steatotic liver disease: Patients with NAFLD had higher BMI, WC, HC, SBP, DBP, AST, ALT, GGT, FPG, 2 h OGTT, uric acid, LDL-c, insulin, HOMA-IR, and hs-CRP compared to control subjects (P < 0.05).